Sony Pixel Power calrec Sony

Progress Announces Second Quarter 2022 Financial Results

28/06/2022

Revenue and EPS Exceed Prior Guidance

BURLINGTON, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS), the trusted provider of infrastructure software, today announced financial results for its fiscal second quarter ended May 31, 2022.

Second Quarter 2022 Highlights:

Revenue of $148.7 million increased 21% year-over-year on an actual currency basis, and 24% on a constant currency basis.

Non-GAAP revenue of $150.9 million increased 17% on an actual currency basis, and 19% on a constant currency basis.

Annualized Recurring Revenue (ARR) of $486 million increased 13% year-over-year on a constant currency basis.

Operating margin was 27% and Non-GAAP operating margin was 41%.

Diluted earnings per share was $0.66 compared to $0.30 in the same quarter last year, an increase of 120%.

Non-GAAP diluted earnings per share was $1.04 compared to $0.82 in the same quarter last year, an increase of 27%.

Once again, we are very pleased to report excellent quarterly results, especially during so much market turmoil and global uncertainty, said Yogesh Gupta, CEO at Progress. Progress again performed exceptionally well across the board, exceeding revenue and EPS guidance, which was driven by a Total Growth Strategy that layers accretive M&A over a highly profitable and predictable business with strong recurring revenue and very high retention rates. Despite a tumultuous market and an economy with increasing risks, Progress remains well positioned to continue our steady execution for the remainder of 2022 and beyond.

Additional financial highlights included(1):

Three Months Ended

GAAP Non-GAAP

(In thousands, except percentages and per share amounts) May 31, 2022 May 31, 2021 % Change May 31, 2022 May 31, 2021 % Change

Revenue $ 148,747 $ 122,488 21 % $ 150,879 $ 129,198 17 %

Income from operations $ 40,235 $ 22,282 81 % $ 61,298 $ 49,712 23 %

Operating margin 27 % 18 % 900bps 41 % 38 % 300bps

Net income $ 29,110 $ 13,557 115 % $ 45,886 $ 36,513 26 %

Diluted earnings per share $ 0.66 $ 0.30 120 % $ 1.04 $ 0.82 27 %

Cash from operations (GAAP) /Adjusted free cash flow (Non-GAAP) $ 68,260 $ 54,690 25 % $ 68,038 $ 55,411 23 %

(1)See Legal Notice Regarding Non-GAAP Financial Information

Other fiscal second quarter 2022 metrics and recent results included:

Cash, cash equivalents and short-term investments were $225.9 million at the end of the quarter.

DSO was 39 days compared to 44 days in the fiscal second quarter of 2021 and 52 days in the fiscal first quarter of 2022.

On June 21, 2022, our Board of Directors declared a quarterly dividend of $0.175 per share of common stock that will be paid on September 15, 2022 to shareholders of record as of the close of business on September 1, 2022.

Anthony Folger, CFO, said: Despite the recent challenges in the global economy, our business continues to perform well across virtually all product lines. Our integration of Kemp is on track, our balance sheet continues to strengthen, and the recurring nature of our revenues and our strong retention rates will continue to serve us well in this environment.

2022 Business Outlook

Progress provides the following guidance for the fiscal year ending November 30, 2022 and the fiscal third quarter ending August 31, 2022:

Updated FY 2022 Guidance

(June 28, 2022) Prior FY 2022 Guidance

(March 29, 2022)

(In millions, except percentages and per share amounts) GAAP Non-GAAP GAAP Non-GAAP

Revenue $601 - $609 $609 - $617 $601 - $609 $609 - $617

Diluted earnings per share $2.11 - $2.21 $4.05 - $4.11 $2.16 - $2.23 $4.01 - $4.09

Operating margin 22% - 23% 39% - 40% 23 % 39% - 40%

Cash from operations (GAAP) /

Adjusted free cash flow (Non-GAAP) $188 - $193 $185 - $190 $188 - $193 $185 - $190

Effective tax rate 21 % 20% - 21% 21 % 20% - 21%

Q3 2022 Guidance

(In millions, except per share amounts) GAAP Non-GAAP

Revenue $145 - $148 $147 - $150

Diluted earnings per share $0.46 - $0.48 $0.96 - $0.98

Based on current exchange rates, the expected negative currency translation impact on Progress fiscal year 2022 business outlook compared to 2021 exchange rates is approximately $11.7 million on GAAP and non-GAAP revenue, and approximately $0.04 on GAAP and non-GAAP diluted earnings per share. The expected negative currency translation impact on Progress fiscal Q3 2022 business outlook compared to 2021 exchange rates on GAAP and non-GAAP revenue is approximately $3.6 million. The expected negative impact on GAAP and non-GAAP diluted Q3 2022 earnings per share is $0.02. To the extent that there are changes in exchange rates versus the current environment, this may have an impact on Progress business outlook.

Conference Call

Progress will hold a conference call to review its financial results for the fiscal second quarter of 2022 at 5:00 p.m. ET on Tuesday, June 28, 2022. The call can be accessed on the investor relations section of the company's website, located at www.progress.com. Additionally, you can listen to the call by telephone by dialing 866-374-5140 or +1 404-400-0571, passcode 186-83-835#. The conference call will include comments followed by questions and answers. An archived version of the conference call and supporting materials will be available on the Progress website within the investor relations section after the live conference call.

Legal Notice Regarding Non-GAAP Financial Information

Progress provides non-GAAP financial information as additional information for investors. These
LINK: https://investors.progress.com/news-releases/news-release-details/prog...
See more stories from datadirect

Most recent headlines

05/01/2027

Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be demoed at CES 2026

Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...

07/10/2026

Dalet Flex LTS Delivers Smarter Media Operations from Ingest to Distribution

Dalet, a leading technology and service provider for media-rich organizations, today announced the latest Long-Term Supported (LTS) release of Dalet Flex. Build...

06/09/2026

Dolby and MagentaTV Bring Fans Closer to the FIFA World Cup 2026 in Germany with Dolby Vision and Dolby Atmos

June 9 2026, 23:00 (PDT) Dolby and MagentaTV Bring Fans Closer to the FIFA Worl...

06/08/2026

FCC Votes to Modify TV Station Ownership Caps

Share Copy link Facebook X Linkedin Bluesky Email...

06/08/2026

LTN Showcases Live Event Master Control Capabilities for...

Proven offering builds on more than 20,000 live sporting events with greater automation, flexibility, and operational control LTN , the industry leader in tran...

06/08/2026

Hornets Tech brings new encoder and decoder range to IBC2...

Hornets Tech, a specialist in broadcast connectivity and IP video, is bringing a new range of encoders, decoders and an IPTV platform to IBC2026. Broadcast in...

06/08/2026

Introducing Adobe for ChatGPT: Create, edit and get work done - all in ChatGPT

Introducing Adobe for ChatGPT: Create, edit and get work done - all in ChatGPT Deepti Pradeep August 6, 2026 0 Comments The Adobe plugin in ChatGPT br...

06/08/2026

Hisense Adds Dolby Vision 2 to Select Models

Share Copy link Facebook X Linkedin Bluesky Email...

06/08/2026

MediaKind to showcase one unified portfolio at IBC2026

At IBC2026, MediaKind will make its first major appearance as a unified global powerhouse in video, showcasing one of the world's most comprehensive video i...

06/08/2026

Big Blue Marble to unveil AI-assisted piracy detection an...

Big Blue Marble (#5.A63) will demonstrate how its integrated technology and operational expertise help media companies scale premium services with less complexi...

06/08/2026

NIH expected to award Scripps Research nearly $4.2 million over 5 years to advance tools for vaccine design

LA JOLLA, CA-Scripps Research has received more than $500,000 in first-year fund...

06/08/2026

Improving vaccine design for Ebola, HIV and more

LA JOLLA, CA-Viruses are masters at invading our cells thanks to specialized proteins that coat their surfaces. When scientists design vaccines, they often crea...

06/08/2026

How a chemical reaction triggers brain inflammation in Alzheimer's disease

LA JOLLA, CA-The brain has its own immune system, which detects threats and mounts a defense. A growing body of evidence has shown that in Alzheimer's disea...

06/08/2026

Jin-Quan Yu elected to the National Academy of Sciences

LA JOLLA, CA-Scripps Research chemist Jin-Quan Yu has been elected to the National Academy of Sciences (NAS), one of the highest honors a scientist can achieve....

06/08/2026

Scripps Research ranks third in 2026 Cure Innovation Index

LA JOLLA, CA-Scripps Research ranked third in the inaugural 2026 Cure Innovation Index recognizing the top-performing institutes and centers across the United S...

06/08/2026

Scripps Research chemist Benjamin Cravatt elected to American Philosophical Society

Benjamin Cravatt, the Gilula Chair of Chemical Biology and a professor of chemis...

06/08/2026

Scripps Research immunologist Dennis Burton elected to American Academy of Arts and Sciences

LA JOLLA, CA-Dennis Burton, professor and the James & Jessie Minor Chair in Immu...

06/08/2026

How changes to proteins can alter drug interactions for new precision therapies

LA JOLLA, CA-Inside every human cell, proteins are constantly being tagged with small chemical modifications after they're produced. Known as post-translati...

06/08/2026

Scripps Research establishes endowed chair honoring renowned structural biologist Ian Wilson

LA JOLLA-Scripps Research has established the Ian Wilson Endowed Chair, a new fa...

06/08/2026

Scripps Research's Skaggs Graduate School awards doctoral degrees to 34th graduating class

Scripps Research's Skaggs Graduate School of Chemical and Biological Science...

06/08/2026

Scripps Research chemist Jin-Quan Yu is named a Fellow of the Royal Society

LA JOLLA, CA-Professor Jin-Quan Yu of Scripps Research has been elected to the Fellowship of the Royal Society, the U.K.'s national academy of sciences and ...

06/08/2026

Experimental HIV vaccine achieves a long-sought goal

LA JOLLA, CA-For years, researchers have been hoping for vaccines that protect people against not just one strain of HIV, but every strain of the quickly mutati...

06/08/2026

Calibr-Skaggs advances CLF065, a regenerative GLP-2 therapy, into two Phase 2 IBD studies

LA JOLLA, CA-The Calibr-Skaggs Institute for Innovative Medicines, the nonprofit...

06/08/2026

Chemists snap together complex 3D molecules from highly reactive radicals'-without losing their shape

LA JOLLA, CA-Building the complex 3D molecules needed for new medicines has alwa...

06/08/2026

A fentanyl countermeasure that adapts to combat future black-market drugs

LA JOLLA, CA-Fentanyl and related variants of the synthetic opioid kill more Americans each year than car accidents and gun violence combined. In too-high doses...

06/08/2026

Two Scripps Research assistant professors named 2026 Baxter Young Investigators

LA JOLLA, CA-What do decoding communication between organs and reimagining the future of genome editing have in common? They're among the scientific questio...

06/08/2026

Calibr-Skaggs awarded $5.1M by NIH to develop long-acting hepatitis B virus therapy

LA JOLLA, CA-Of the 1.2 million people living with HIV in the United States, app...

06/08/2026

Lab studies explain how new cancer drug works as it enters patient testing

LA JOLLA, CA-For some people, cancer immunotherapies are life-changing. These treatments can turn the body's own immune system against a tumor, either elimi...

06/08/2026

Newly identified molecule strengthens the eye's response to damage in retinal disease

LA JOLLA, CA-Many conditions that cause vision loss share a common feature: the ...

06/08/2026

Molecular scissors caught in action: A structural blueprint for RNA therapeutics

LA JOLLA, CA-RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not. Crowned with the 2006 Nobel Priz...

06/08/2026

Immune molecule may drive excessive drinking in alcohol use disorder

LA JOLLA, CA-The drugs that keep rheumatoid arthritis in check may one day help people stop drinking. A new Scripps Research study shows that an anti-inflammato...

06/08/2026

Back in action: Researchers make drug-resistant bacteria vulnerable again

LA JOLLA, CA-Antibiotic resistance is one of the most urgent threats to global health, linked to an estimated 4.7 million deaths worldwide in 2019 alone. As mor...

06/08/2026

Scripps Research scientists demonstrate a faster, cheaper route to making critical drugs using common table sugar

LA JOLLA, CA-Some of the world's best-selling diabetes drugs depend on a che...

06/08/2026

Scripps Research scientists awarded $2M to advance global disease surveillance

LA JOLLA, CA-Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak. Technologies such as...

06/08/2026

Joan Pulupa joins Scripps Research faculty to study the organization of DNA in brain cells and its links to neurodegeneration

LA JOLLA, CA-Molecular biophysicist Joan Pulupa will join Scripps Research in Ja...

06/08/2026

Scripps Research scientists train the immune system to make antibodies against numerous HIV strains

LA JOLLA, CA-HIV is globally so diverse, consisting of hundreds of thousands of ...

06/08/2026

ASG Ups Michele Ferreira to Chief Business Officer

Share Copy link Facebook X Linkedin Bluesky Email...

06/08/2026

WNBC and WNJU Expand New York Giants Deal

Share Copy link Facebook X Linkedin Bluesky Email...

06/08/2026

Utah Scientific to Highlight NBOSS at IBC 2026

Share Copy link Facebook X Linkedin Bluesky Email...

06/08/2026

Disney, TikTok Ink Global Short-Form Content-Sharing Deal

Share Copy link Facebook X Linkedin Bluesky Email...

06/08/2026

Kane Peterson Joins QuickLink's North America Team

Share Copy link Facebook X Linkedin Bluesky Email...

06/08/2026

FCC Returns $881 Million in Unused TV Broadcaster Relocation Funds

Share Copy link Facebook X Linkedin Bluesky Email...

06/08/2026

PlayBox Neo to highlight secure and scalable workflow del...

At this year's SET EXPO, PlayBox Neo will present recent innovations across its PlayBox Neo Suite and integrated range of broadcast media solutions. By show...

06/08/2026

Modern Streaming Solutions Private Limited Partners with...

Live demo at IBC2026 VisualOn Booth, Hall 5, Stand A55 Amsterdam, Netherlands Modern Streaming Solutions Private Limited, a rising force in India's dig...

06/08/2026

Screen Australia and YouTube Australia fund five new teams through eleventh Skip Ahead initiative

Screen Australia and YouTube Australia fund five new teams through eleventh Skip...

06/08/2026

How Karukera Studio Built a Media Production Hub with SNS EVO

How Karukera Studio Built a Media Production Hub with SNS EVO Melanie Ciotti August 5, 2026 0 Comments Hero images displays Karukera Studio in Sainte-...

06/08/2026

NHK drama series Rosanjin no Kamado shot on PYXIS 6K

NHK drama series Rosanjin no Kamado shot on PYXIS 6K Brie Clayton August 5, 2026 0 Comments Blackmagic PYXIS 6K and DaVinci Resolve Studio capture the...

06/08/2026

Camera Match: AutoSetup 3d Plugin / script for Photomontages- Cinema 4D

Camera Match: AutoSetup 3d Plugin / script for Photomontages- Cinema 4D Jamie Cardoso August 5, 2026 0 Comments If you do any kind of Architectural Vi...

06/08/2026

Documentary on the life and impact of Dnal Lunny to air on RT

In Time airs Monday 10 August at 9.35pm on RT One and RT Player In Time is the first film account of the life of D nal Lunny, one of the most influential Iri...

06/08/2026

Into the Omniverse: How Open World Models Push the Frontier of Physical AI

Editor's note: This post is part of Into the Omniverse, a series focused on how developers, 3D practitioners and enterprises can transform their workflows u...